Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-03-09 9:40 pm Unchanged |
2021-03-08 | 13G | PHAXIAM Therapeutics S.A. PHXM |
BIOTECHNOLOGY VALUE FUND L P | 408,194 19.300% |
0 (Unchanged) |
Filing History |
| 2021-03-08 4:54 pm Purchase |
2021-03-04 | 13G | FIVE PRIME THERAPEUTICS INC FPRX |
BIOTECHNOLOGY VALUE FUND L P | 6,338,678 13.800% |
3,200,000 (+101.95%) |
Filing History |
| 2021-03-05 4:33 pm Purchase |
2020-10-14 | 13G | 5:01 Acquisition Corp. FVAM |
BIOTECHNOLOGY VALUE FUND L P | 500,000 5.800% |
500,000 (New Position) |
Filing History |
| 2021-02-19 5:10 pm Unchanged |
2021-02-17 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
BIOTECHNOLOGY VALUE FUND L P | 8,383,645 9.960% |
0 (Unchanged) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2021-02-11 | 13D | Infinity Pharmaceuticals, Inc. INFIQ |
BIOTECHNOLOGY VALUE FUND L P | 8,383,645 13.100% |
-2,343,323 (-21.85%) |
Filing History |
| 2021-02-16 4:17 pm Sale |
2020-12-31 | 13G | NOVUS THERAPEUTICS INC NVUS |
BIOTECHNOLOGY VALUE FUND L P | 1,503,121 9.990% |
-14,918 (-0.98%) |
Filing History |
| 2021-02-12 9:17 pm Purchase |
2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
BIOTECHNOLOGY VALUE FUND L P | 4,274,965 9.990% |
1,942,335 (+83.27%) |
Filing History |
| 2021-02-12 8:57 pm Purchase |
2020-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
BIOTECHNOLOGY VALUE FUND L P | 1,719,616 9.990% |
59,141 (+3.56%) |
Filing History |
| 2021-02-12 8:17 pm Purchase |
2020-12-31 | 13G | F-star Therapeutics, Inc. FSTX |
BIOTECHNOLOGY VALUE FUND L P | 25,844 1.000% |
25,844 (New Position) |
Filing History |
| 2021-02-12 8:16 pm Purchase |
2020-12-31 | 13G | Spero Therapeutics, Inc. SPRO |
BIOTECHNOLOGY VALUE FUND L P | 2,768,278 9.990% |
739,873 (+36.48%) |
Filing History |
| 2021-02-12 7:58 pm Sale |
2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA |
BIOTECHNOLOGY VALUE FUND L P | 954,996 6.800% |
-45,004 (-4.50%) |
Filing History |
| 2021-02-12 7:23 pm Purchase |
2020-12-31 | 13G | Regulus Therapeutics Inc. RGLS |
BIOTECHNOLOGY VALUE FUND L P | 705,046 9.990% |
495,376 (+236.26%) |
Filing History |
| 2021-02-12 6:52 pm Sale |
2020-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE |
BIOTECHNOLOGY VALUE FUND L P | 3,499,346 10.000% |
-17,505 (-0.50%) |
Filing History |
| 2021-02-12 6:47 pm Purchase |
2020-12-31 | 13G | SUNESIS PHARMACEUTICALS INC CO SNSS |
BIOTECHNOLOGY VALUE FUND L P | 1,814,308 9.980% |
1,814,308 (New Position) |
Filing History |
| 2021-02-12 5:16 pm Purchase |
2020-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
BIOTECHNOLOGY VALUE FUND L P | 3,710,689 7.400% |
894,299 (+31.75%) |
Filing History |
| 2021-02-12 5:03 pm Purchase |
2020-12-31 | 13G | Genocea Biosciences, Inc. GNCA |
BIOTECHNOLOGY VALUE FUND L P | 5,285,549 9.990% |
2,123,881 (+67.18%) |
Filing History |
| 2021-02-12 4:25 pm Sale |
2020-12-31 | 13G | Sutro Biopharma, Inc. STRO |
BIOTECHNOLOGY VALUE FUND L P | 1,854,162 4.100% |
-514,230 (-21.71%) |
Filing History |
| 2021-02-12 4:22 pm Purchase |
2020-12-31 | 13G | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 2,972,191 8.100% |
1,027,645 (+52.85%) |
Filing History |
| 2021-02-12 4:20 pm Sale |
2020-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
BIOTECHNOLOGY VALUE FUND L P | 70,020 9.990% |
-3,390 (-4.62%) |
Filing History |
| 2021-02-12 4:18 pm Sale |
2020-12-31 | 13G | Ovid Therapeutics Inc. OVID |
BIOTECHNOLOGY VALUE FUND L P | 4,522,051 6.900% |
-733,250 (-13.95%) |
Filing History |